U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11410161 on NIH RePORTER |
What this research studies
This program brings U.S. and East African teams together to improve prevention and early detection of cancers linked to HIV, especially cervical cancer and Kaposi’s sarcoma. It builds a collaborative network of hospitals and researchers across the regions to run coordinated projects and share best practices. The center funds career development so emerging African investigators can lead local research and build sustainable services. Participating clinics will pilot improved screening, diagnostic methods, and systems to make sure people found to have cancer are quickly connected to treatment.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV in the East African regions served by the partner clinics, including women at risk for cervical cancer and people at risk for Kaposi’s sarcoma who may be offered screening or prevention services.
Not a fit: People without HIV or those living outside the participating East African catchment areas are unlikely to be directly helped by this program.
Why it matters
Potential benefit: If successful, this work could lead to more screening, earlier cancer diagnosis, and quicker access to treatment for people with HIV in East Africa.
How similar studies have performed: Screening and linkage programs have improved cancer outcomes in other settings, but combining regional capacity building with focused HIV-related cancer prevention and early detection in East Africa is a relatively new and less-tested approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.